Statistics

Total Visits

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period162

File Visits

Downloads
35543-24.pdf128

Select a period of time:

Number of views in the range

Views
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period50

Number of downloads in the range

Downloads
35543-24.pdf60

Views

Views
December 20258
January 202614
February 20260
March 202611
April 20268
May 20265
June 20264
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    4
  • January 2026
    1
  • February 2026
    0
  • March 2026
    16
  • April 2026
    11
  • May 2026
    18
  • June 2026
    10
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States30
United Kingdom5
Brazil3
Germany2
Argentina2
Angola1
Belgium1
Colombia1
Ecuador1
Hong Kong1
 

Top countries by downloads

Downloads
United States27
Germany8
United Kingdom3
Argentina1
Ecuador1
 

Top cities views

Views
San Jose18
São Paulo2
Los Angeles2
Ashburn1
Avondale Estates1
Bogotá1
Bragança Paulista1
Cabimas1
Córdoba1
Denver1
 

Top cities by downloads

Downloads
Ashburn3